Keyphrases
Virus Infection
100%
Small Interfering RNA (siRNA)
100%
Lipids
100%
Marburg Virus
100%
Angola
23%
Virus Strains
15%
Messenger RNA (mRNA)
15%
% Protection
15%
Lipid Nanoparticles
15%
Guinea pig
7%
Survival Rate
7%
Further Development
7%
Potential Therapeutics
7%
Beneficial Effects
7%
Severe Morbidity
7%
Nonhuman Primate
7%
Effective Treatment
7%
Protective Efficacy
7%
Human Primates
7%
MiRNA Target
7%
Guinea pig Model
7%
Live Virus
7%
In Vitro Testing
7%
In Vivo Evaluation
7%
High Survival
7%
Nanoparticle Technology
7%
Dual-luciferase Reporter Assay
7%
In Vitro Development
7%
Pharmacology, Toxicology and Pharmaceutical Science
Virus Infection
100%
Small Interfering RNA
100%
Marburg Virus
100%
Virus Strain
15%
Solid Lipid Nanoparticle
15%
Guinea Pig
7%
Survival Rate
7%
Luciferase
7%
Guinea Pig Model
7%
Virus Messenger RNA
7%
Messenger RNA
7%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Small Interfering RNA
100%
Marburgvirus
100%
Virus Strain
15%
Messenger RNA
15%
Guinea Pig
7%
Survival Rate
7%
Luciferase
7%
Guinea Pig Model
7%
Immunology and Microbiology
Viral Disease
100%
Marburgvirus
100%
Virus Strain
15%
Survival Rate
7%
Guinea Pig
7%
Guinea Pig Model
7%